Rogério Serafim Parra

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops et al. · The Lancet · 2022 · 277 citations

Immunology, Clinical Trials, Gastroenterology +7

Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil

Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Heda M B S Amarante et al. · World Journal of Gastroenterology · 2019 · 82 citations · Full text

Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress

Pedro V. da Silva‐Neto, Valéria B. do Valle, Carlos Alessandro Fuzo et al. · Biomolecules · 2022 · 53 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Lung Inflammation +20

sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity

Pedro V. da Silva‐Neto, Jonatan C. S. de Carvalho, Vinícius E. Pimentel et al. · Viruses · 2021 · 47 citations · Full text

Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity

Malena M. Pérez, Vinícius E. Pimentel, Carlos Alessandro Fuzo et al. · The Journal of Immunology · 2022 · 34 citations · Full text